Evidence map›Paper›PMID 36678876›Full record

ArticlePharmaceutics2023

Improved Metal-Free Approach for the Synthesis of Protected Thiol Containing Thymidine Nucleoside Phosphoramidite and Its Application for the Synthesis of Ligatable Oligonucleotide Conjugates.

Zoltán Kupihár, Györgyi Ferenc, Vencel L Petrovicz, Viktória R Fáy, Lajos Kovács, Tamás A Martinek, Zsófia Hegedüs

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zoltán KupihárDepartment of Medical Chemistry, University of Szeged, Dom ter 8., H-6720 Szeged, Hungary.
Györgyi FerencInstitute of Plant Biology, Biological Research Centre, Eötvös Lóránd Research Network, H-6726 Szeged, Hungary.ORCID 0000-0002-3456-319X
Vencel L PetroviczDepartment of Medical Chemistry, University of Szeged, Dom ter 8., H-6720 Szeged, Hungary.
Viktória R FáyDepartment of Medical Chemistry, University of Szeged, Dom ter 8., H-6720 Szeged, Hungary.
Lajos KovácsDepartment of Medical Chemistry, University of Szeged, Dom ter 8., H-6720 Szeged, Hungary.ORCID 0000-0002-0331-3980
Tamás A MartinekDepartment of Medical Chemistry, University of Szeged, Dom ter 8., H-6720 Szeged, Hungary.
Zsófia HegedüsDepartment of Medical Chemistry, University of Szeged, Dom ter 8., H-6720 Szeged, Hungary.ORCID 0000-0002-5546-8167
University of Szeged · HUHUN-REN Szegedi Biológiai Kutatóközpont · HU

Funding

Ministry of Innovation and Technology of Hungary through the National Research, Development and Innovation Fund TKP2021-EGA-32National Research, Development and Innovation Office of Hungary K 128801National Research, Development and Innovation Office of Hungary K134754National Research, Development and Innovation Office of Hungary NKFIH PD 135324
6 · The paper itself

Abstract

Oligonucleotide conjugates are versatile scaffolds that can be applied in DNA-based screening platforms and ligand display or as therapeutics. Several different chemical approaches are available for functionalizing oligonucleotides, which are often carried out on the 5' or 3' end. Modifying oligonucleotides in the middle of the sequence opens the possibility to ligate the conjugates and create DNA strands bearing multiple different ligands. Our goal was to establish a complete workflow that can be applied for such purposes from monomer synthesis to templated ligation. To achieve this, a monomer is required with an orthogonal functional group that can be incorporated internally into the oligonucleotide sequence. This is followed by conjugation with different molecules and ligation with the help of a complementary template. Here, we show the synthesis and the application of a thiol-modified thymidine nucleoside phosphoramidite to prepare ligatable oligonucleotide conjugates. The conjugations were performed both in solution and on solid phase, resulting in conjugates that can be assembled into multivalent oligonucleotides decorated with tissue-targeting peptides using templated ligation.

Indexed as

ligatable oligonucleotidesnucleoside synthesisoligonucleotide conjugatessolid-phase conjugationtemplated ligationthiol-maleimide conjugation

Identifiers

PMID36678876
PMCPMC9865093
OpenAlexW4315647890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.